25K0 Intrinsic Valuation and Fundamental Analysis - Karyopharm Therapeutics Inc

	Karyopharm Therapeutics Inc F:25K0	US
	Takeda Pharmaceutical Co Ltd F:TKD	JP
	Profound Medical Corp TSX:PRN	CA
C	Clariant AG F:CLRN	CH
E	Erste Group Bank AG XMUN:EBO	AT
V	Vitesco Technologies Group AG DUS:VTSC	DE
	H World Group Ltd F:CL4	CN
U	United States Steel Corp F:USX1	US
F	Fortis Inc F:12F	CA

Intrinsic Value

The intrinsic value for Karyopharm Therapeutics Inc (25K0) under the Base Case is hidden EUR. Compared with the current market price of 5.7 EUR, the stock appears hidden .

Intrinsic value calculated using Multiples

Locked

Other reference points

DCF valuation

Locked

Wall St target

€6.98

Do our valuations actually work? See backtest results .

25K0 Intrinsic Value

Unlock

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Margin of Safety 20% Locked

Current Price €5.7

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

25K0 looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if 25K0 is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Karyopharm Therapeutics Inc.

Explain Valuation